1. Introduction {#sec1-ijerph-14-01019}
===============

There has been a rapid increase in non-communicable disease (NCD)-related deaths in Asian---including Greater Mekong---countries. NCDs---in particular cardiovascular disorders (CVDs), cancer, diabetes, and chronic respiratory disease---are now the major cause of death and disease burden in the region \[[@B1-ijerph-14-01019],[@B2-ijerph-14-01019]\]. The epidemiological transition from communicable to NCDs has been taking place in Southeast Asia, creating a public health challenge \[[@B3-ijerph-14-01019]\]. NCDs are the number-one killer in the South Asia region, accounting for 55% of all death \[[@B4-ijerph-14-01019]\]. Globally, half of the people with NCDs have two or more conditions (multimorbidity) \[[@B5-ijerph-14-01019]\]. Multimorbidity may be defined as "the coexistence of multiple chronic conditions in a given individual" \[[@B6-ijerph-14-01019]\]. Based on the research to date \[[@B5-ijerph-14-01019]\], there seems to be no consensus on which conditions should be considered or on the method used for measuring multimorbidity \[[@B7-ijerph-14-01019]\]. Evidence from low-income settings is limited \[[@B7-ijerph-14-01019],[@B8-ijerph-14-01019],[@B9-ijerph-14-01019]\].

In a South African primary health care study, hypertension was the most common comorbid condition in type 2 diabetes, epilepsy, asthma, and chronic obstructive pulmonary disease (COPD), and diabetes and hypertension was the most common combination \[[@B10-ijerph-14-01019]\]. Chronic condition (hypertension, diabetes, asthma, COPD, epilepsy, and osteoarthritis) multimorbidity (two or more conditions) was present in 36.4% of patients with COPD, 23.7% with osteoarthritis, 16.3% with diabetes, 15.3% with asthma, 12.0% with hypertension, and 6.7% with epilepsy \[[@B10-ijerph-14-01019]\]. About half of the patients with chronic conditions had comorbidity, and multimorbidity was common in patients with COPD and osteoarthritis \[[@B10-ijerph-14-01019]\]. In a large primary care population with one of 24 chronic diseases aged 55 years and older in the Netherlands, the mean multimorbidity was the highest for CVD (3.39--4.97), COPD (3.40), visual disorder (3.38), rheumatoid arthritis (3.28), asthma (3.24), Parkinson's disease (3.23), anxiety disorder (3.21), depression (3.10), osteoarthritis (3.03), and the lowest in hypertension (2.57), migraine (2.62), cancer (2.85), musculoskeletal disorder (2.95), and epilepsy (2.98) \[[@B11-ijerph-14-01019]\]. In a large primary care practice database in the United States, the prevalence of multimorbidity (two or more chronic conditions) of 24 chronic diseases was 45.2% \[[@B12-ijerph-14-01019]\]. A pattern of chronic conditions that was observed was, for example, between atherosclerosis and hypertension, coronary heart disease, diabetes mellitus, and hyperlipidaemia \[[@B12-ijerph-14-01019]\].

Factors associated with the multimorbidity of chronic conditions (two or more chronic conditions) may include older age \[[@B8-ijerph-14-01019],[@B10-ijerph-14-01019],[@B13-ijerph-14-01019],[@B14-ijerph-14-01019],[@B15-ijerph-14-01019]\], women \[[@B8-ijerph-14-01019],[@B13-ijerph-14-01019],[@B15-ijerph-14-01019]\], better education \[[@B14-ijerph-14-01019],[@B15-ijerph-14-01019]\], higher wealth index \[[@B14-ijerph-14-01019],[@B15-ijerph-14-01019]\], lower socioeconomic status \[[@B8-ijerph-14-01019]\], urban residence \[[@B14-ijerph-14-01019]\], and low quality of life \[[@B16-ijerph-14-01019]\]. There is a lack of studies investigating multimorbidity among chronic disease patients, especially in Southeast Asia. Therefore, the aim of this study was to explore the prevalence, pattern, and social determinants of chronic conditions multimorbidity among chronic disease primary care patients in four Greater Mekong countries.

2. Materials and Methods {#sec2-ijerph-14-01019}
========================

Sample and Procedure
--------------------

In the study countries (Cambodia, Myanmar, Thailand, and Vietnam), a cross-sectional survey in rural and urban primary health facilities was conducted among out-patients with chronic diseases. The study facilities were convenience-selected. Each eligible patient aged ≥18 years with a chronic disease was selected from the health facility, using a systematic sampling procedure; more details can be found in \[[@B17-ijerph-14-01019],[@B18-ijerph-14-01019]\].

Trained research assistants conducted interviews with the patients using structured questionnaires after obtaining informed consent. For this study, patients with one of these 21 chronic conditions were invited in the study: asthma, COPD, diabetes mellitus, hypertension, dyslipidaemia, coronary artery disease, cardiac failure, cardiac arrhythmias, stroke, arthritis, cancer, gout, Parkinson's disease, liver disease, kidney disease, thyroid disease, stomach and intestinal diseases, epilepsy, and mental disorders \[[@B11-ijerph-14-01019],[@B19-ijerph-14-01019]\]. In addition, information on four chronic conditions (daily tobacco use, alcohol use disorder, anxiety, and depression) and on dietary behaviour, physical activity, and quality of life was assessed with structured questionnaires. In Cambodia, the National Ethics Committee for Health Research, Ministry of Health, Cambodia (Reference No.: 0225NECHR); in Myanmar the Research and Ethical Committee, University of Medicine 1, Yangon; and in Vietnam the Committee for Research Ethics, Hanoi School of Public Health; and in Thailand, the Committee for Research Ethics in Social Sciences, Mahidol University (COA. No.: 2014/193.0807), approved the study protocol.

3. Measures {#sec3-ijerph-14-01019}
===========

Tobacco use was assessed with four questions: "(1) Do you currently smoke any tobacco products, such as cigarettes, cigars or pipes?" If they answered yes, they were asked "(2) Do you currently smoke tobacco products daily? (3) Do you currently use any smokeless tobacco, such as snuff, chewing tobacco, betel?" If they answered yes, they were asked "(4) Do you currently use smokeless tobacco products daily?" \[[@B20-ijerph-14-01019]\].

Alcohol use disorder was assessed using the Alcohol Use Disorder Identification Test (AUDIT)-C with a cut-off score of four defined as problem drinking \[[@B21-ijerph-14-01019]\] (Cronbach alpha 0.81).

The Hospital Anxiety and Depression Scale (HADS) \[[@B22-ijerph-14-01019]\] was used to assess anxiety (seven items) and depression (seven items). A score of ≥11 was used to define anxiety and depression \[[@B22-ijerph-14-01019]\] (Cronbach alpha was 0.73 and 0.71 for anxiety and for depression, respectively).

Dietary behaviour was assessed with seven items: consumption of fast food, fruits and vegetables, sweet drinks, protein, chips and crackers, desserts and fats during the previous 7 days \[[@B23-ijerph-14-01019]\]. From these seven items, we calculated a total dietary score of up to 14 points with 0 points signifying the best dietary habits and 14 signifying the poorest dietary habits \[[@B23-ijerph-14-01019]\].

Physical activity was assessed using the General Physical Activity Questionnaire (GPAQ) \[[@B24-ijerph-14-01019]\]. The total physical activity score was used to divide participants into inactive and moderately or highly active \[[@B24-ijerph-14-01019]\].

Quality of life was assessed with the World Health Organization Quality of Life (WHOQol)-8, consisting of eight items that were derived from the WHOQOL-Bref \[[@B25-ijerph-14-01019]\]. The eight-item index consists of two items from each domain of the original WHOQOL-BREF (physical, psychological, environmental, and social) \[[@B26-ijerph-14-01019]\], and showed acceptable cross-cultural performance and a satisfactory discriminant validity \[[@B26-ijerph-14-01019]\]. Results from the two-item sub-scales and the eight-item index were summed to get sub-scale and overall WHOQoL scores, which was then transformed to a 0--100 scale, which was grouped into low, medium, and high QoL (Cronbach alpha 0.88).

Sociodemographic data obtained from all participants were age, sex, country, formal education level, marital status, and residency status.

4. Data Analysis {#sec4-ijerph-14-01019}
================

Data were analysed using the IBM Statistical Package for the Social Sciences (SPSS) for Windows version 24.0 (SPSS, Inc., Chicago, IL, USA). The proportions of chronic diseases were calculated as percentages, means, and standard deviations. Multinomial logistic regression was used by comparing two chronic conditions and three or more chronic conditions multimorbidity prevalence with having only one chronic condition (reference category). Predictor variables included sociodemographic factors, quality of life, and behavioural risk factors (physical inactivity and poor diet). Probability below 0.05 was regarded as statistically significant.

5. Results {#sec5-ijerph-14-01019}
==========

The total sample included 6236 public primary care patients; 67.2% were female, 1594 from Cambodia, 1533 from Myanmar, 1549 from Thailand, and 1560 from Vietnam. The mean age of the study population was 53.0 years (SD = 16.8), ranging 18 to 94 years. More than half (59.8%) were 50 years and older, 62.0% had six or more years of education, and 45.9% were residing in urban areas. Almost half of the participants (43.1%) reported a low quality of life, 29.4% were physically inactive, and 39.3% had a poor dietary behaviour.

From 17 health record-assessed chronic conditions (coronary artery disease, cardiac failure, cardiac arrhythmias and stroke were combined into CVD) and four interview-based assessed chronic conditions (depression, anxiety, alcohol use disorder, and daily tobacco use), the most common was hypertension (37.4%), followed by depression (34.4%), digestive diseases (32.0%), anxiety (19.4%), musculoskeletal diseases (16.4%), type 2 diabetes (17.2%), daily tobacco use (16.0%), CVD (15.9%), and arthritis (15.9%). In all, 27.4% had one chronic condition, 28.6% had two, 22.4% had three, and 21.6% had four or more chronic conditions. The percentage with the highest comorbidity was depression (47.3%), followed by hypertension (43.4%), digestive diseases (34.1%), anxiety (26.6%), daily tobacco use (22.0%), CVD (20.0%), type 2 diabetes (18.9%), arthritis (18.3%), and musculoskeletal diseases (18.1%). The highest mean multimorbidity reported was for mental illness (4.44), followed by kidney disease (4.11), Parkinson's disease (4.10), anxiety (3.74), daily tobacco use (3.62), migraine (3.62), depression (3.58), CVD (3.57), and COPD (3.56), and the lowest multimorbidity was found for epilepsy (2.43), followed by cancer (2.80) and asthma (2.82). Comparing the younger (18--49 years) with the older age group (50--94 years), in most chronic conditions the mean multimorbidity was higher among the older than younger age group, except for a few conditions: CVD, COPD, mental illness, cancer, and Parkinson's disease (see [Table 1](#ijerph-14-01019-t001){ref-type="table"}).

[Table 2](#ijerph-14-01019-t002){ref-type="table"} describes the top ten chronic conditions that were comorbid with six major chronic conditions. Of those who had hypertension, the highest comorbidity was with depression (34.6%), type 2 diabetes (24.8%), CVD (20.6%), and dyslipidaemia (19.0%). Hypertension had the highest comorbidity with type 2 diabetes (56.7%), CVD (48.5%), and musculoskeletal diseases (29.4%). The major comorbid chronic conditions with COPD were depression (56.9%), digestive diseases (36.2%), and daily tobacco use (31.1%) (see [Table 2](#ijerph-14-01019-t002){ref-type="table"}).

Compared to those who had only one chronic condition, being male, older age, lower education, and lower quality of life were associated with having two and three or more chronic conditions. In addition, rural residence and poor dietary behaviour were associated with three or more chronic conditions (see [Table 3](#ijerph-14-01019-t003){ref-type="table"}).

6. Discussion {#sec6-ijerph-14-01019}
=============

The study found that among chronic condition primary care patients in four Greater Mekong countries, the majority (72.6%) had multimorbidity (as also found in previous studies \[[@B5-ijerph-14-01019],[@B11-ijerph-14-01019],[@B12-ijerph-14-01019]\]), and even higher than in South Africa \[[@B10-ijerph-14-01019]\]. This study found that hypertension was the most common comorbid condition in type 2 diabetes, COPD, CVD, and musculoskeletal diseases, while a previous study in South Africa found that it was the most common comorbid condition in type 2 diabetes, epilepsy, asthma, and COPD \[[@B10-ijerph-14-01019]\]. Similar to a previous study among primary care patients in the Netherlands with 24 chronic conditions \[[@B11-ijerph-14-01019]\], this study found that the highest mean multimorbidity was among patients with mental disorders and CVD and lowest for cancer, epilepsy, and hypertension patients.

As reviewed previously \[[@B27-ijerph-14-01019],[@B28-ijerph-14-01019],[@B29-ijerph-14-01019]\], in this study depression was a very common comorbid condition of type 2 diabetes, CVD, COPD, and arthritis, and anxiety was a common comorbid condition in CVD. This finding has also been confirmed in a systematic review \[[@B30-ijerph-14-01019]\] where "depression was found to be the disease that was most commonly clustered, and was paired with 8 different diseases." Further, as also found in the systematic review \[[@B30-ijerph-14-01019]\], this study found that hypertension was the second most clustered disease with type 2 diabetes, CVD, and musculoskeletal diseases, while this was only partially true for type 2 diabetes which only highly clustered with hypertension. A common chronic conditions pattern included hypertension, type 2 diabetes, CVD, and dyslipidaemia, which was similarly observed among US American primary care patients \[[@B12-ijerph-14-01019]\]. Some of the most common chronic condition comorbidity patterns may be explained by having a common pathophysiology \[[@B31-ijerph-14-01019]\].

In agreement with previous studies \[[@B8-ijerph-14-01019],[@B10-ijerph-14-01019],[@B13-ijerph-14-01019],[@B14-ijerph-14-01019],[@B15-ijerph-14-01019]\], this study found that older chronic condition patients were more likely to have chronic condition multimorbidity than younger patients, which is consistent with the idea that additional life years add additional opportunities to develop other chronic conditions \[[@B8-ijerph-14-01019]\]. Contrary to some previous studies \[[@B8-ijerph-14-01019],[@B13-ijerph-14-01019],[@B15-ijerph-14-01019]\], this study found an association between male gender and chronic condition multimorbidity. The higher prevalence of chronic condition multimorbidity among men in this sample may be because alcohol and tobacco use disorders were included in the 21 chronic conditions assessed. These two substance use disorders were much more common in men than women in this study (analysis not shown). In this study, the likelihood of chronic condition multimorbidity was higher in those with lower education. This finding was also found in some other studies \[[@B8-ijerph-14-01019],[@B13-ijerph-14-01019]\], while in a study in India and Indonesia \[[@B14-ijerph-14-01019],[@B15-ijerph-14-01019]\], better education was associated with chronic condition multimorbidity. This study did not find an association between income or economic status and chronic condition multimorbidity, while other studies found mixed results \[[@B8-ijerph-14-01019],[@B14-ijerph-14-01019],[@B15-ijerph-14-01019]\].

This study may confirm the existence of an inverse association between chronic condition multimorbidity and quality of life, as found in a previous review \[[@B16-ijerph-14-01019]\]. The possible association between chronic condition multimorbidity and quality of life may have additional health care management implications in the study countries \[[@B9-ijerph-14-01019]\]. In a recent review \[[@B32-ijerph-14-01019]\], health-related quality of life in older adults with multimorbidity was ranked as the most important research topic to improve their health and health care.

This study has several limitations. This was a cross-sectional study, so causal conclusions cannot be drawn. The investigation was conducted among chronic patients from conveniently selected health facilities in the study countries, and inclusion of other health facilities could have resulted in different findings. The preselection of chronic disease patients in this study design prevented us from reporting the overall prevalence of multimorbidity among out-patients, in general resulting in a probably higher prevalence of multimorbidity among chronic disease patients. A further limitation was that the rate of health utilization among the different chronic condition patients was not assessed. This study used a count of chronic conditions as a measure of multimorbidity, implying that each chronic condition has an equal impact on an individual, while in reality disease severity, the specific combination of chronic conditions, and access to health care may affect multimorbidity.

7. Conclusions {#sec7-ijerph-14-01019}
==============

This study from public primary health care providers found a high chronic condition multimorbidity among chronic disease patients in four Greater Mekong countries. Common patterns of chronic condition multimorbidity---e.g., hypertension was strongly comorbid with depression, type 2 diabetes, CVD, and dyslipidaemia, and CVD was strongly comorbid with hypertension and depression---were identified that could help in the development of chronic condition multimorbidity guidelines and management plans in this setting. Older male patients of lower education in a rural area seem to be at the highest risk of multimorbidity, particularly in the presence of a poor diet.
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###### 

Chronic condition morbidity pattern in the sample population.

  Chronic Condition                       \%     Percentage with Comorbidity   Mean Multimorbidity (SD)-Total   Mean Multimorbidity (SD)-18--49 Years   Mean Multimorbidity (SD)-50--94 Years
  --------------------------------------- ------ ----------------------------- -------------------------------- --------------------------------------- ---------------------------------------
  Hypertension                            37.4   43.5                          2.98 (1.5)                       2.83 (1.6)                              3.01 (1.5)
  Depression                              34.4   47.3                          3.58 (1.3)                       3.39 (1.3)                              3.70 (1.3)
  Digestive diseases                      32.0   34.1                          2.99 (1.7)                       2.59 (1.6)                              3.59 (1.7)
  Anxiety                                 19.4   26.6                          3.74 (1.3)                       3.51 (1.3)                              3.88 (1.3)
  Musculoskeletal diseases                16.4   18.1                          3.04 (1.7)                       2.84 (1.8)                              3.14 (1.7)
  Type 2 diabetes                         16.4   18.9                          3.02 (1.5)                       2.86 (1.5)                              3.05 (1.5)
  Daily tobacco use                       16.0   22.0                          3.62 (1.4)                       3.45 (1.4)                              3.70 (1.7)
  CVD ^1^                                 15.9   20.0                          3.57 (1.7)                       3.83 (1.9)                              3.47 (1.6)
  Arthritis                               15.9   18.3                          3.54 (1.8)                       3.26 (1.9)                              3.30 (1.6)
  Dyslipidaemia                           10.4   13.8                          3.46 (1.4)                       3.06 (1.4)                              3.64 (1.4)
  Alcohol use disorder                    7.8    10.6                          3.44 (1.3)                       3.28 (1.3)                              3.73 (1.4)
  Migraine or frequent headaches          7.0    8.0                           3.62 (2.0)                       3.33 (1.9)                              4.10 (1.8)
  Chronic obstructive pulmonary disease   5.6    6.9                           3.56 (1.8)                       3.74 (1.9)                              3.48 (1.8)
  Asthma                                  4.5    4.5                           2.82 (1.9)                       2.52 (1.9)                              3.07 (1.9)
  Kidney disease                          4.5    5.4                           4.11 (1.9)                       3.92 (1.9)                              3.99 (1.7)
  Liver disease                           4.1    4.8                           3.07 (1.7)                       2.77 (1.7)                              3.46 (1.7)
  Mental illness                          2.4    3.0                           4.44 (2.2)                       4.55 (2.3)                              4.32 (2.0)
  Thyroid disease                         1.8    2.0                           3.03 (1.8)                       2.59 (1.6)                              3.38 (1.7)
  Cancer                                  1.5    1.6                           2.80 (1.6)                       2.93 (1.7)                              2.74 (1.5)
  Parkinson's disease                     1.6    1.8                           4.10 (2.6)                       5.30 (2.6)                              3.45 (2.3)
  Epilepsy                                0.4    0.3                           2.43 (1.9)                       2.40 (2.0)                              2.67 (0.6)

^1^ Coronary artery diseases (186, 3.8%), cardiac failure (370, 7.5%), cardiac arrhythmias (144, 2.9%), stroke (182, 3.7%). CVD: cardiovascular disease.
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###### 

The top ten chronic conditions that were comorbid with each chronic condition. COPD: chronic obstructive pulmonary disease.

  Hypertension *N* = 2331    Type 2 Diabetes *N* = 1022   CVD *N* = 992              COPD *N* = 351   Arthritis *N* = 991        Musculoskeletal Diseases *N* = 1025                                                                                              
  -------------------------- ---------------------------- -------------------------- ---------------- -------------------------- ------------------------------------- -------------------------- ------ -------------------------- ------ ---------------------- ------
  Depression                 34.6                         Hypertension               56.7             Hypertension               48.5                                  Depression                 56.9   Depression                 47.5   Hypertension           29.4
  Type 2 diabetes            24.8                         Depression                 34.3             Depression                 47.6                                  Digestive diseases         36.2   Digestive diseases         40.0   Digestive diseases     26.0
  CVD                        20.6                         Anxiety                    20.7             Digestive diseases         26.2                                  Daily tobacco use          31.1   Hypertension               28.5   Depression             24.4
  Dyslipidaemia              19.0                         Dyslipidaemia              19.5             Anxiety                    23.2                                  CVD                        20.8   Musculoskeletal diseases   22.0   Arthritis              21.3
  Anxiety                    18.9                         Daily tobacco use          13.1             Arthritis                  18.4                                  Anxiety                    20.6   Anxiety                    20.8   Daily tobacco use      17.1
  Daily tobacco use          16.9                         CVD                        11.3             Daily tobacco use          17.9                                  Hypertension               19.4   CVD                        18.5   Anxiety                16.5
  Digestive diseases         14.6                         Digestive diseases         12.1             Musculoskeletal diseases   13.3                                  Arthritis                  17.9   Daily tobacco use          18.4   CVD                    12.9
  Musculoskeletal diseases   12.9                         Arthritis                  7.5              Dyslipidaemia              12.2                                  Musculoskeletal diseases   12.3   Migraine                   12.2   Alcohol use disorder   10.0
  Arthritis                  12.1                         Musculoskeletal diseases   7.5              Type 2 diabetes            11.6                                  Migraine                   8.3    Kidney disease             8.4    Dyslipidaemia          9.5
  Alcohol use disorder       5.3                          Alcohol use disorder       3.8              Migraine                   9.1                                   Asthma                     7.4    Type 2 diabetes            7.8    Migraine               9.4
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###### 

Multinomial logistic regression model examining correlates of multimorbidity.

  Variable                  Two Chronic Conditions versus One Chronic Condition   Three or More Chronic Conditions versus One Chronic Condition
  ------------------------- ----------------------------------------------------- ---------------------------------------------------------------
  Sex                                                                             
   Female                   1 (Reference)                                         1 (Reference)
   Male                     1.80 (1.43, 2.26) \*\*\*                              2.19 (1.77, 2.71) \*\*\*
  Age (in years)                                                                  
   18--49                   1 (Reference)                                         1 (Reference)
   50--94                   1.36 (1.11, 1.67) \*\*                                1.83 (1.52, 2.21) \*\*\*
  Education                                                                       
   Grade 0--5               1 (Reference)                                         1 (Reference)
   Grade 6--11              0.78 (0.62, 0.99) \*                                  0.44 (0.36, 0.54) \*\*\*
   Grade 12 or more         0.59 (0.44, 0.78) \*\*\*                              0.30 (0.23, 0.39) \*\*\*
  Income                                                                          
   Low                      1 (Reference)                                         1 (Reference)
   High                     1.05 (0.85, 1.30)                                     0.97 (0.80, 1.18)
  Geolocality                                                                     
   Urban                    1 (Reference)                                         1 (Reference)
   Rural                    1.06 (0.86, 1.32)                                     1.24 (1.02, 1.51) \*
  Quality of Life                                                                 
   Low                      1 (Reference)                                         1 (Reference)
   Medium                   0.69 (0.50, 0.96) \*                                  0.47 (0.34, 0.64) \*\*\*
   High                     0.77 (0.62, 0.96) \*                                  0.65 (0.54, 0.79) \*\*\*
  Physical inactivity                                                             
   No                       1 (Reference)                                         1 (Reference)
   Yes                      0.90 (0.73, 1.13)                                     1.20 (0.98, 1.46)
  Poor diet index (scale)   1.07 (0.88, 1.31)                                     1.26 (1.05, 1.52) \*

\*\*\* *p* \< 0.001; \*\* *p* \< 0.01; \* *p* \< 0.05; AOR = Adjusted Odds Ratio; CI = Confidence Interval.
